Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Sep 29, 2022 10:18pm
325 Views
Post# 34996613

RE:RE:Warrants extension

RE:RE:Warrants extension
99942Apophis wrote: enriquesuave wrote

They may expect SP to head quite a bit higher soon enough to have those excercised and fund company until Approval?  We shall see.  



What I found curious was mentioned only the October 3rd $ 0.50 warrants to be extended by an additional year. Also coming into experation are 4,095,157 at a price of $0.50 on January 9, 2023. 
Would this suggest that the December update will clearly put us well above the exercise price so that the company will receive that additional funding from both January 9th and October 3rd in 2023 and not require tapping into a financial raise until a much higher dollar value is reached.



It seems they have a $$ path to get to the many $$$ Millions of warrants that come due end of Aug 2024. 

Tons will happen by then, We'll see IF they need another small PP along the way at much higher SP??

<< Previous
Bullboard Posts
Next >>